Health care-associated pneumonia in the intensive care unit: Guideline-concordant antibiotics and outcomes.

[1]  N. Dean,et al.  Derivation and Multicenter Validation of the Drug Resistance in Pneumonia Clinical Prediction Score , 2016, Antimicrobial Agents and Chemotherapy.

[2]  T. Lagu,et al.  Association of guideline-based antimicrobial therapy and outcomes in healthcare-associated pneumonia. , 2015, The Journal of antimicrobial chemotherapy.

[3]  M. Fine,et al.  Association of azithromycin with mortality and cardiovascular events among older patients hospitalized with pneumonia. , 2014, JAMA.

[4]  A. Torres,et al.  Epidemiology, antibiotic therapy and clinical outcomes of healthcare-associated pneumonia in critically ill patients: a Spanish cohort study , 2014, Intensive Care Medicine.

[5]  S. Ewig,et al.  Healthcare-associated pneumonia does not accurately identify potentially resistant pathogens: a systematic review and meta-analysis. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  M. Niederman,et al.  A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  H. Saka,et al.  Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia. , 2013, American journal of respiratory and critical care medicine.

[8]  J. Rello,et al.  Microbial aetiology of healthcare associated pneumonia in Spain: a prospective, multicentre, case–control study , 2013, Thorax.

[9]  F. Blasi,et al.  Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: a European perspective , 2013, Thorax.

[10]  M. Kollef,et al.  A risk score for identifying methicillin-resistant Staphylococcus aureus in patients presenting to the hospital with pneumonia , 2013, BMC Infectious Diseases.

[11]  A. El‐Solh,et al.  Guideline-Concordant Antimicrobial Therapy for Healthcare-Associated Pneumonia: A Systematic Review and Meta-analysis , 2013, Lung.

[12]  H. Vikram,et al.  Guideline-concordant antibiotic therapy and clinical outcomes in healthcare-associated pneumonia. , 2012, Respiratory medicine.

[13]  E. Bouza,et al.  Pneumonia treated in the internal medicine department: focus on healthcare-associated pneumonia. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[14]  T. Marrie,et al.  Macrolide-based regimens and mortality in hospitalized patients with community-acquired pneumonia: a systematic review and meta-analysis. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  S. Corrao,et al.  Clinical impact of broad-spectrum empirical antibiotic therapy in patients with healthcare-associated pneumonia: a multicenter interventional study , 2012, Internal and Emergency Medicine.

[16]  C Michael Stein,et al.  Azithromycin and the risk of cardiovascular death. , 2012, The New England journal of medicine.

[17]  V. Fan,et al.  Guideline-Based Antibiotics and Mortality in Healthcare-Associated Pneumonia , 2012, Journal of General Internal Medicine.

[18]  J. Abisheganaden,et al.  Short-term mortality among older persons hospitalized for pneumonia: influence of baseline patient characteristics beyond severity of illness. , 2012, Journal of hospital medicine.

[19]  V. Fan,et al.  Predicting antibiotic resistance to community-acquired pneumonia antibiotics in culture-positive patients with healthcare-associated pneumonia. , 2012, Journal of hospital medicine.

[20]  J. Dorca,et al.  Low incidence of multidrug-resistant organisms in patients with healthcare-associated pneumonia requiring hospitalization. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[21]  C. Frei,et al.  Health care-associated pneumonia: an evidence-based review. , 2011, The American journal of medicine.

[22]  A. Akram,et al.  Epidemiology, antibiotic therapy, and clinical outcomes in health care-associated pneumonia: a UK cohort study. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  J. Pépin,et al.  Impact of guideline-consistent therapy on outcome of patients with healthcare-associated and community-acquired pneumonia. , 2011, The Journal of antimicrobial chemotherapy.

[24]  A. Anzueto,et al.  Guideline-concordant therapy and outcomes in healthcare-associated pneumonia , 2011, European Respiratory Journal.

[25]  J. Ramirez,et al.  Implementation of guidelines for management of possible multidrug-resistant pneumonia in intensive care: an observational, multicentre cohort study. , 2011, The Lancet. Infectious diseases.

[26]  D. Benoit,et al.  Nursing home residence is the main risk factor for increased mortality in healthcare-associated pneumonia. , 2011, The Journal of hospital infection.

[27]  L. Tsu,et al.  Practice patterns for antibiotic de-escalation in culture-negative healthcare-associated pneumonia , 2010, Infection.

[28]  A. Shorr,et al.  Resistant pathogens in nonnosocomial pneumonia and respiratory failure: is it time to refine the definition of health-care-associated pneumonia? , 2010, Chest.

[29]  T. Welte,et al.  Rethinking the concepts of community-acquired and health-care-associated pneumonia. , 2010, The Lancet. Infectious diseases.

[30]  J. Chalmers,et al.  Proposed changes to management of lower respiratory tract infections in response to the Clostridium difficile epidemic. , 2010, The Journal of antimicrobial chemotherapy.

[31]  Marin H Kollef,et al.  Prediction of infection due to antibiotic-resistant bacteria by select risk factors for health care-associated pneumonia. , 2008, Archives of internal medicine.

[32]  M. Kollef,et al.  Health Care-Associated Pneumonia and Community-Acquired Pneumonia: a Single-Center Experience , 2007, Antimicrobial Agents and Chemotherapy.

[33]  J. Dorca,et al.  Health care-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes. , 2007, Archives of internal medicine.

[34]  J. Bartlett,et al.  Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[35]  Marin H Kollef,et al.  Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. , 2005, Chest.

[36]  R. Laing,et al.  Community‐acquired pneumonia: influence of management practices on length of hospital stay , 2004, Internal medicine journal.

[37]  W. Lim,et al.  Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study , 2003, Thorax.

[38]  M. Fine,et al.  A prediction rule to identify low-risk patients with community-acquired pneumonia. , 1997, The New England journal of medicine.

[39]  R. Deyo,et al.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.